Natto: New Evidence: Vitamin K2-Fortified Yogurt Helps Improve Heart Health

A new study shows that consumption of yogurt fortified with MenaQ7® improves
Vitamin K2 status significantly for healthy people, contributing to improved
cardiovascular health.
OSLO, NORWAY and METUCHEN, NJ (November 5th 2015) – The Journal of Nutritional
Science recently published a study1 that adds to the growing body of evidence
showing that Vitamin K2 is a safe and effective supplement. Additionally, it
shows that Vitamin K2 as MenaQ7® can be absorbed through yogurt, which makes the
nutrient available to an even larger population.

“Consumers already recognize yogurt as a healthy choice. The fact that we can
now enrich yogurt with a vitamin that the majority of the population is
deficient is a major breakthrough. The study’s results imply that we, by adding
MenaQ7 to a popular food item, can bring significant health benefits to a larger
percentage of people,” says Eric Anderson, senior vice president of global sales
and marketing at NattoPharma, exclusive global supplier of MenaQ7 Vitamin K2 as
MK-7.

A number of studies have previously shown that supplementation with MenaQ7
Vitamin K2 improved cardiovascular health by reducing age-related arterial
calcification, and improved bone health by increasing bone density and mass. .
The new study, in which healthy patients received low doses of MK7 in a yogurt
drink for three months, shows that the benefits of Vitamin K2 can be obtained
through other delivery systems than traditional dietary supplements.

“This study not only confirms that short-term use of MenaQ7 can improve health,
but also that yogurt is an effective way of providing the public with this
important nutrient,” says Hogne Vik, CEO of NattoPharma. “We already have
clinical documentation showing that children generally have a deficiency of
Vitamin K2. The confirmation that our ingredient also works in a yogurt product
is an important step forward. This means that we can make the nutrient available
to more people, reach a younger audience, and create a healthier generation.”

To view the new study in The Journal of Nutritional Science, visit:
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=1000643
9 
&fileId=S2048679015000257.

Reference:

1 Knapen MHJ, Braam LAJL, Teunissen KJ, Zwijsen RML, Theuwissen E, Vermeer C.
Yogurt drink fortified with menaquinone-7 improves vitamin K status in healthy
population. J Nutr Sci. 2015; 4:e35 doi:10.1017/jns.2015.25.

# # #

About MenaQ7®

MenaQ7® is the best documented, commercially available vitamin K2 as MK-7 with
guaranteed actives and stability, clinical substantiation, and international
patents granted and pending. MenaQ7® is available in two varieties: natural
vitamin K2 as MK-7 Crystals and nature-identical synthetic vitamin K2 as MK-7
PURE. For more information on the health benefits of MenaQ7, visit menaq7.com.

About NattoPharma

NattoPharma ASA, based in Norway, is the world’s leader in vitamin K2 research
and development. NattoPharma is the exclusive international supplier of MenaQ7®
Vitamin K2 as MK-7, and has a multi-year research and development program to
substantiate and discover the health benefits of vitamin K2 for applications in
the marketplace for functional food and dietary supplements. With a global
presence, the company established its North American subsidiary, NattoPharma
USA, Inc., in Metuchen, NJ. For more information, visit nattopharma.com.

For more information, please contact:

Hogne Vik, CEO NattoPharma
Cell phone: +47 97 53 53 26
E-mail: hogne.vik@nattopharma.com

Kate Quackenbush, Director of Communications
NattoPharma USA, Inc.
Phone: 609-643-0749
E-mail: kate.quackenbush@nattopharma.com